Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2021-04-16
Product name
LAPATINIB 250 MG TABLETS
Product Synonyms
GW572016F 250 MG TABLETS * LAPATINIB DITOSYLATE MONOHYDRATE, FORMULATED
1.2.1 Relevant identified uses
Bulk Formulated Product
supplier name
GlaxoSmithKline Korea
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Hazard Codes
Hazard statements (CLP)
H413
Hazard statements
Code
Statements
H413
May cause long lasting harmful effects to aquatic life
Section 2
SECTION 2: Hazards identification
A. Hazard category/Classification
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Hazardous to the aquatic environment, Category 4
Long term hazards
B. Warning label items including precautionary statement
Hazard pictograms
None.
Signal word
None.
Hazard statements
H413 May cause long lasting harmful effects to aquatic life.
Prevention
P273 Avoid release to the environment.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations. C. Other hazards not included Caution - Pharmaceutical agent. See section 11 for additional information on health hazards. in the hazard category criteria (e.g. dust explosion hazard)
Additional information
41.7 % of the mixture consists of component(s) of unknown acute oral toxicity. 97.1 % of the mixture consists of component(s) of unknown acute dermal toxicity. 53.4 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 47.1 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
